Finance

Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
544,00 ₹
-0,86%
(-4,70) 1D
14 հոկ, 09:41:10 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
548,00 ₹
High
560,00 ₹
Low
542,55 ₹
Mkt. cap
10,88 մլրդ
Avg. vol.
32,60 հզր
Volume
4,53 հզր
Dividend
0,33%
Quarterly dividend
0,45 ₹
Ex-dividend date
11 սեպ, 2026 թ.
P/E ratio
11,30
52-wk high
770,00 ₹
52-wk low
440,00 ₹
EPS
48,16 ₹
Shares outstanding
20,00 մլն
No. of employees
1 հզր
Open
548,00 ₹
High
560,00 ₹
Low
542,55 ₹
Mkt. cap
10,88 մլրդ
Avg. vol.
32,60 հզր
Volume
4,53 հզր
Dividend
0,33%
Quarterly dividend
0,45 ₹
Ex-dividend date
11 սեպ, 2026 թ.
P/E ratio
11,30
52-wk high
770,00 ₹
52-wk low
440,00 ₹
EPS
48,16 ₹
Shares outstanding
20,00 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1,35 հզր
Founded1979
Headquarters-
Sector-
Last report
13 օգս, 2026 թ.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,77 մլրդ / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,63 մլրդ
1,66 մլրդ
1,87 մլրդ
1,77 մլրդ
Cost of goods sold
767,46 մլն
759,60 մլն
967,33 մլն
851,43 մլն
Cost of revenue
767,46 մլն
759,60 մլն
967,33 մլն
851,43 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303,56 մլն
306,18 մլն
389,12 մլն
333,10 մլն
Operating expense
648,09 մլն
704,87 մլն
684,68 մլն
685,91 մլն
Total operating expenses
1,42 մլրդ
1,46 մլրդ
1,65 մլրդ
1,54 մլրդ
Operating income
218,09 մլն
198,75 մլն
220,76 մլն
235,48 մլն
Other non operating income
72,32 մլն
151,46 մլն
-379,32 մլն
242,65 մլն
EBT including unusual items
288,11 մլն
347,22 մլն
167,03 մլն
475,54 մլն
EBT excluding unusual items
288,11 մլն
347,22 մլն
146,26 մլն
475,54 մլն
Income tax expense
88,27 մլն
61,22 մլն
50,68 մլն
113,19 մլն
Effective tax rate
30,64%
17,63%
30,34%
23,80%
Other operating expenses
308,34 մլն
361,49 մլն
258,73 մլն
313,96 մլն
Net income
199,84 մլն
286,00 մլն
116,35 մլն
362,34 մլն
Net profit margin
12,23%
17,20%
6,21%
20,44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
82,21 մլն
-
Interest expense
-2,31 մլն
-2,98 մլն
-
-2,59 մլն
Net interest expenses
-2,31 մլն
-2,98 մլն
82,21 մլն
-2,59 մլն
Depreciation and amortization charges
36,19 մլն
37,21 մլն
36,83 մլն
38,84 մլն
EBITDA
253,58 մլն
230,69 մլն
256,62 մլն
271,73 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps